logo

For the Inventor, By the Inventor

Suphanburi, Thailand

Sutisak Kitareewan

This inventor holds 3 USPTO granted patents. Top assignee: Dartmouth College. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sutisak Kitareewan. Retrieved from https://idiyas.com/inventor/sutisak-kitareewan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Subhanburi, TH (2012)
  • Ordford, NH (US) (2012)
  • Suphanburi, TH (2014)

Company Filing History:

goldMedal3 out of 706 
 
Dartmouth College
 patents

Years Active: 2012-2014

Loading Chart...
3 patents (USPTO):Explore Patents
1. 8697668 - Compositions and methods for preventing and treating cancer via modulating UBE1L, ISG215 and/or UBP43 (2014-04-15),
2. 8283113 - Compositions and methods for preventing and treating cancer via modulating UBE1L, ISG15 and/or UBP43 (2012-10-09),
3. 8124371 - Compositions and methods for destabilizing lysosomes to increase oncogenic or aberrant protein degradation (2012-02-28),

Title: Innovations in Cancer Treatment by Sutisak Kitareewan

Introduction

Sutisak Kitareewan is a notable inventor based in Suphanburi, Thailand. He has made significant contributions to the field of cancer research through his innovative patents. With a total of 3 patents, his work focuses on compositions and methods for preventing and treating cancer.

Latest Patents

Kitareewan's latest patents include groundbreaking methods for cancer treatment. One of his patents describes compositions and methods for preventing and treating cancer by modulating UBE1L, ISG215, and/or UBP43. These compositions aim to induce UBE1L or a ubiquitin-like protein ISG15, or inhibit a deconjugase UBP43 to degrade oncogenic proteins. This process enhances apoptosis in cancerous or pre-cancerous cells. Another patent reiterates similar methods for the prevention or treatment of cancer through the administration of these innovative compositions.

Career Highlights

Sutisak Kitareewan is affiliated with Dartmouth College, where he continues to advance his research in cancer treatment. His work is characterized by a commitment to developing effective therapeutic strategies that target cancer at the molecular level.

Collaborations

Kitareewan collaborates with esteemed colleagues such as Ethan Dmitrovsky and Ian Pitha-Rowe. Their combined expertise contributes to the advancement of cancer research and the development of innovative treatment methods.

Conclusion

Sutisak Kitareewan's contributions to cancer research through his patents highlight the importance of innovation in medical science. His work not only showcases his dedication to improving cancer treatment but also emphasizes the collaborative efforts in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…